Cost-effectiveness analyses of docetaxel versus paclitaxel once weekly in patients with metastatic breast cancer in progression following anthracycline chemotherapy, in Spain

  1. Frías, C.
  2. Cortés, J.
  3. Seguí, M.Á.
  4. Oyagüez, I.
  5. Casado, M.Á.
Aldizkaria:
Clinical and Translational Oncology

ISSN: 1699-048X

Argitalpen urtea: 2010

Alea: 12

Zenbakia: 10

Orrialdeak: 692-700

Mota: Artikulua

DOI: 10.1007/S12094-010-0579-4 GOOGLE SCHOLAR